
One tablet. Once a month.
-
When a bisphosphonate is appropriate for postmenopausal osteoporosis
-
Ask your newly diagnosed and current bisphosphonate patients if they would
prefer once-monthly dosing
-
Delivers bisphosphonate efficacy*
-
Offers the convenience of monthly dosing
-
Instruct patients to take with water on an empty stomach upon rising in the
morning, and to remain upright and in fasting state for at least 60 minutes...
only once-monthly
-
Tolerability profile
-
BONIVA
150 mg monthly similar to daily dose
-
BONIVA
2.5 mg daily similar to placebo
*BONIVA
is indicated for the treatment and prevention of osteoporosis in postmenopausal
women.
BONIVA
is contraindicated in patients unable to stand or sit upright for at least
60 minutes or with uncorrected hypocalcemia.
BONIVA
is contraindicated in patients with known hypersensitivity to
BONIVA
or any of its components.
Read full Prescribing Information.